SiliconInvestor
     Advanced Search   [ sign in ]

register
Sponsor		  register
Register

 Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?


To: Vector1 who wrote (9095)1/3/2002 11:59:18 PM
From: SpekulatiusRead Replies (1) | Respond to of 9719
 
>> Cyberken, tough start for the year for biotechs. Looks like the HQ effect is being overshadowed by the IMCL effect.
<<
I think its more likely that money is rotating out of biotechs into cyclical techs (chips etc.). IMCL and ABGX problems certainly do not help.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.